It has moved into the mainstream where it is recommended as a factor in a drug used by millions of people every day " said Larry Lesko, director of the clinical pharmacology office at the FDA.
FDA clarifies label of warfarin →
"Doctors and other health care professionals may well decide to incorporate genetic information, along with more traditional risk factors, in estimating their patients' warfarin doses," Dr. Lesko said. "It may improve the safe use of warfarin."
Be the first to know